GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » Revenue per Share

HSCS (HeartSciences) Revenue per Share : $0.07 (TTM As of Jul. 2024)


View and export this data going back to 2022. Start your Free Trial

What is HeartSciences Revenue per Share?

HeartSciences's revenue per share for the three months ended in Jul. 2024 was $0.00. HeartSciences's revenue per share for the trailing twelve months (TTM) ended in Jul. 2024 was $0.07.

Warning Sign:

HeartSciences Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue Per Share Growth Rate of HeartSciences was 170.80% per year. During the past 3 years, the average Revenue Per Share Growth Rate was -45.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for HeartSciences's Revenue per Share or its related term are showing as below:

HSCS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -57.1   Med: -51.05   Max: -45
Current: -45

During the past 5 years, HeartSciences's highest 3-Year average Revenue Per Share Growth Rate was -45.00% per year. The lowest was -57.10% per year. And the median was -51.05% per year.

HSCS's 3-Year Revenue Growth Rate is ranked worse than
94.74% of 741 companies
in the Medical Devices & Instruments industry
Industry Median: 7.1 vs HSCS: -45.00

HeartSciences Revenue per Share Historical Data

The historical data trend for HeartSciences's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences Revenue per Share Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24
Revenue per Share
0.80 0.33 0.17 0.06 0.05

HeartSciences Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.04 0.03 - -

Competitive Comparison of HeartSciences's Revenue per Share

For the Medical Devices subindustry, HeartSciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeartSciences's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's PS Ratio distribution charts can be found below:

* The bar in red indicates where HeartSciences's PS Ratio falls into.



HeartSciences Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

HeartSciences's Revenue Per Share for the fiscal year that ended in Apr. 2024 is calculated as

Revenue Per Share (A: Apr. 2024 )=Revenue (A: Apr. 2024 )/Shares Outstanding (Diluted Average) (A: Apr. 2024 )
=0.019/0.353
=0.05

HeartSciences's Revenue Per Share for the quarter that ended in Jul. 2024 is calculated as

Revenue Per Share (Q: Jul. 2024 )=Revenue (Q: Jul. 2024 )/Shares Outstanding (Diluted Average) (Q: Jul. 2024 )
=0/0.778
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeartSciences  (NAS:HSCS) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


HeartSciences Revenue per Share Related Terms

Thank you for viewing the detailed overview of HeartSciences's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HeartSciences Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092